Antineuronal antibody screening in early onset-cognitive decline.

The article presents case study of 54-year-old woman who went to hospital after a 6-week progressive history of decreased movement, weight loss and abouliaticle. It mentions she was treated for anti-glycine receptor encephalitis involving methylprednisolone, intravenous immunoglobulins and rituximab. It adds question raised over testing for autoimmune encephalitides in patients with early onset-cognitive decline.